Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Posanski; Ulrich
Address:
Freiburg, DE
No. of patents:
19
Patents:












Patent Number Title Of Patent Date Issued
7511014 Cyclosporin galenic forms March 31, 2009
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.
7235248 Pharmaceutical compositions comprising cyclosporins June 26, 2007
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2-Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weigh
7081445 Cyclosporin galenic forms July 25, 2006
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.
6844459 Pharmaceutical Composition January 18, 2005
Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesteri
6503883 Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis January 7, 2003
The invention relates to a pharmaceutical preparation, which contains an immunosuppressive active agent in dissolved form in a starch capsule, or hard or soft gelatin capsule which has been coated with one or several polymer films. The invention further relates to a process for the p
6468968 Cyclosporin galenic forms October 22, 2002
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.
6262022 Pharmaceutical compositions containing cyclosporin as the active agent July 17, 2001
Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesteri
6258808 Pharmaceutical composition July 10, 2001
Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-,di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterif
6204243 Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis March 20, 2001
The invention relates to a pharmaceutical preparation, which contains an immunosuppressive active agent in dissolved form in a starch capsule, or hard or soft gelatin capsule which has been coated with one or several polymer films. The invention further relates to a process for the p
6024978 Pharmaceutical compositions comprising cyclosporins February 15, 2000
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 -alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular we
6007840 Pharmaceutical compositions comprising cyclosporins December 28, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5962017 Pharmaceutical compositions comprising cyclosporins October 5, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5962014 Pharmaceutical compositions comprising cyclosporins October 5, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5916589 Pharmaceutical compositions comprising cyclosporins June 29, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5866159 Pharmaceutical compositions comprising cyclosporins February 2, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5756450 Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutic May 26, 1998
A combination of a pharmacologically active compound and a water soluble monoester of a saturated or unsaturated (C.sub.6-18) fatty acid and a polyol, especially a saccharide, particularly as a solid solution of the active compound in the monoester.The solid solution is especially suitab
5741512 Pharmaceutical compositions comprising cyclosporins April 21, 1998
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5342625 Pharmaceutical compositions comprising cyclosporins August 30, 1994
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
4567161 Liquid active ingredient concentrates for preparation of microemulsions January 28, 1986
Liquid, active substance formulations containing an active substance insoluble or poorly soluble in water, or a mixture, a phospholipid, a special co-emulsifier (glycerinester in which the 1 or 2 OH groups have been esterized with hydrocarbon atoms of 8-16, preferably 8-10, C atoms by










 
 
  Recently Added Patents
System and method for generating profile morphing using cephalometric tracing data
Disk drive to enable defect margining
Handheld electronic device with text disambiguation employing advanced editing feature
Adaptive flow for thermal cooling of devices
Flame-proofed thermoplastic compositions
System and methods for weak authentication data reinforcement
Solid-state imaging apparatus
  Randomly Featured Patents
Multiple reboiler system
Retractable arched window covering
Ziegler-Natta polymerization of alpha-olefins in the presence of non-polymerizing olefins
Stable isotopic identification and method for identifying products by isotopic concentration
Fare box
Oligonucleotides and nucleic acids for detection of ureaplasma urealyticum
Rotisserie with lighting fixture
Method for transmitting information present at a plurality of data interfaces of a processor-controlled equipment to the processing device thereof
Twin column hoist
Disposable ribbon cartridge for shorthand machines